DOI: 10.1055/s-00000088

TumorDiagnostik & Therapie

References

Lamond NW, Skedgel C, Younis T.
Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?.

Expert review of pharmacoeconomics & outcomes research 2013;
13: 243-250

Download Bibliographical Data

Access:
Access: